查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1379093

吸入麻醉市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Inhalation Anesthesia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球吸入麻醉市场规模达16亿美元。展望未来， IMARC Group预计到2028年市场规模将达到19亿美元，2022-2028年复合年增长率（CAGR）为2.9%。慢性疾病的盛行率日益上升，製药公司、医疗器材製造商和医疗机构之间的合作，以及政府和私人医疗保健提供者对最先进设备的投资不断增加，是推动市场的一些主要因素。

吸入麻醉是一种医疗技术，用于使接受各种外科手术的患者进入可逆的意识丧失和对疼痛不敏感的状态。此方法涉及透过呼吸面罩或放置在患者气道中的气管内管以气体或蒸气形式施用麻醉剂。这些麻醉剂，如一氧化二氮、七氟醚、异氟醚和地氟醚，经过仔细平衡，以达到所需的镇静和疼痛缓解水平，同时维持重要的身体功能。吸入的麻醉药物通过患者的呼吸系统，到达肺部，然后进入血液，最终影响大脑和中枢神经系统。

需要手术治疗的慢性疾病的日益普及正在推动全球市场的发展。此外，随着经济的发展和个人更好地获得医疗保健服务，医疗保健支出往往会增加。这包括对医疗设备和技术（包括麻醉设备）的投资。政府和私人医疗保健提供者愿意投资最先进的设备，以改善病患照护和安全。此外，与病人安全和麻醉实践相关的法规和指南可能会影响所使用的麻醉剂和设备的类型。市场成长通常与遵守这些法规一致，这可以导致采用更新的技术和代理。此外，製药公司、医疗器材製造商和医疗机构之间的合作可以促进新麻醉技术的开发和推广，推动市场扩张。此外，熟练的麻醉专业人员对于安全有效地实施吸入麻醉至关重要。培训计划和维持一支合格的麻醉人员队伍的努力可能会影响对这些技术的需求。

吸入麻醉市场趋势/驱动因素：

麻醉剂和输送系统的不断进步

製药公司和医疗设备製造商正在大力投资研发，以创造更有效、更安全的麻醉气体和蒸气。这些创新旨在透过降低不良反应的风险和改善整体麻醉体验来提高患者的治疗效果。正在开发具有改进的药物动力学特征的新型药物，能够更快地诱导和苏醒，从而缩短患者在手术室的时间。此外，复杂的输送系统（包括精确的蒸发器和监控技术）的开发可确保麻醉剂的准确给药和滴定，最大限度地减少剂量过量或不足的可能性。这些进步不仅有助于更好的患者护理，还吸引医疗保健提供者采用这些现代解决方案，从而促进吸入麻醉市场的成长。

手术数量和患者数量不断增加

人口成长通常伴随着人口老化，与外科手术需求的增加直接相关。由于与年龄相关的疾病，例如心血管疾病、关节置换和癌症治疗，老年人口往往需要更多的医疗干预。因此，骨科、心臟病学、肿瘤学和一般外科等外科专业的需求增加。由于起效快且镇静深度可控，吸入麻醉被证明是这些手术的首选。它在确保患者失去知觉和维持其生理稳定性之间提供了平衡。此外，医学知识和技术的扩展拓宽了可行手术介入的范围。微创手术、机器人辅助手术和其他创新技术的出现，使得介入措施更加安全快速。

扩建门诊手术中心

ASC 具有许多优势，例如成本效益、缩短患者住院时间以及降低医院获得性感染的风险。吸入麻醉起效快、恢復快，非常符合 ASC 的要求。在 ASC 接受手术的患者通常更喜欢吸入麻醉，因为这样可以让他们更快恢復日常活动。此外，吸入麻醉能够最大限度地减少术后噁心和呕吐，这在门诊环境中特别有价值。随着ASC数量的增长以满足门诊手术不断增长的需求，吸入麻醉的需求预计将大幅增加。这一趋势也鼓励製造商开发更便携、更用户友好的麻醉输送系统，以满足 ASC 的独特需求。

吸入麻醉产业细分：

IMARC Group提供了全球吸入麻醉市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据产品、应用和最终用户对市场进行了分类。

按产品划分：

地氟烷

七氟醚

异氟烷

其他的

七氟醚占据市场主导地位

该报告根据产品提供了详细的市场细分和分析。这包括地氟烷、七氟烷、异氟烷等。根据该报告，七氟烷是最大的部分。

七氟醚的受欢迎很大程度上是由于其良好的药物动力学特征。凭藉其快速诱导和苏醒的特点，七氟烷使麻醉师能够引导患者快速、平稳地进入和退出麻醉。这不仅提高了医疗环境的运作效率，还确保患者在手术开始和结束时经历的延迟最小。此外，七氟醚的低血气溶解度可以实现肺部和血流之间的快速平衡，从而更快地调整麻醉深度并有可能更快地恢復。七氟醚引起器官毒性或损害生命功能的可能性降低，为医疗专业人员和患者提供了一定程度的安心。这项安全性对于巩固七氟醚作为吸入麻醉实践基石的作用至关重要，特别是在安全性至关重要的儿科和老年人群中。

按应用划分：

就职

维护

维护主导市场

该报告根据应用程式提供了详细的市场细分和分析。这包括归纳和维护。根据该报告，维护是最大的部分。

维护阶段的重要性归因于其在确保患者舒适度、手术精确度和最佳结果方面的作用。一旦患者被诱导进入麻醉状态并进行初始手术切口，保持适当的麻醉深度就变得至关重要。麻醉人员仔细滴定吸入麻醉剂，以平衡患者对疼痛完全不敏感的需求，同时避免过度镇静，过度镇静可能导致併发症或延长恢復时间。这种动态平衡需要在整个过程中持续监测和调整，这凸显了熟练麻醉师的重要性。此外，维持阶段与手术效果和精确度直接相关。外科医生依靠患者充分麻醉和固定来准确地执行精细的手术。维持阶段麻醉深度的任何波动都可能导致患者移动或意识不清，这可能会影响手术的成功。

按最终用户划分：

医院

门诊手术中心

其他的

医院主导市场

该报告提供了基于最终用户的详细市场细分和分析。这包括医院、门诊手术中心等。报告称，医院占最大部分。

医院提供多样化的医疗服务，包括常规手术、紧急干预以及各个医学专业的专门手术。医院进行的外科手术数量庞大、种类繁多，对麻醉服务产生了巨大的需求，而吸入麻醉能够提供快速诱导和可调节镇静水平，与医院手术室的动态环境无缝结合。此外，医院也为麻醉管理和病患照护提供全面的基础设施。他们拥有设备齐全的手术室、先进的监测系统以及能够处理各种病例的经验丰富的麻醉团队。这种强大的设置使医院能够有效管理与不同手术相关的复杂性，包括需要吸入麻醉的手术。此外，医院内专门部门的存在，例如儿科和心臟外科部门，凸显了吸入麻醉在不同病患群体和程序要求中的多功能性。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的吸入麻醉市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）、亚太地区（中国、日本、印度、韩国、澳洲、印尼等）、欧洲（德国） 、法国、英国、义大利、西班牙、俄罗斯等）、拉丁美洲（巴西、墨西哥等）以及中东和非洲。报告称，北美占据最大的市场份额。

北美的特点是重视医疗进步和创新。着名研究机构、学术医疗中心和尖端製药公司的存在创造了一个有利于开发新型麻醉剂、给药方法和监测技术的环境。这种对创新的承诺不仅改善了患者护理，还吸引了医疗保健专业人员采用最先进的麻醉实践，包括吸入麻醉技术。该地区的监管环境和对严格安全标准的遵守进一步增强了其主导地位。美国食品药物管理局 (FDA) 等监管机构在确保麻醉剂和设备的安全性和有效性方面发挥关键作用。这种严格的监督增强了医疗保健提供者和患者对使用吸入麻醉的信心，巩固了北美作为该领域领导者的地位。此外，北美对医学教育和培训的重视确保了麻醉提供者能够安全有效地实施吸入麻醉。

竞争格局：

製药和医疗器材公司正在大力投资研发，以创造先进的麻醉剂、输送系统和监测技术。此外，该公司经常推出新的吸入麻醉产品和设备，以满足医疗保健提供者和患者不断变化的需求。这些产品通常采用最新的技术进步，例如更精确的汽化器、整合监控系统和使用者友善的介面。此外，领先企业正在专注于开发创新技术，以加强吸入麻醉的管理和监测。这包括整合电子病历 (EMR) 系统、即时资料分析和远端监控功能，以确保最佳的患者护理和安全。此外，许多公司正在为医疗保健专业人员提供培训和教育计划，包括麻醉师、护理麻醉师和手术室工作人员。这些计划有助于确保医疗保健提供者精通与吸入麻醉相关的最新技术、技术和安全措施。

该报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

艾伯维公司

百特国际公司

费森尤斯股票公司

卤碳产品公司

希克马製药公司

鲁南製药集团股份有限公司

默克公司

皮拉马尔企业有限公司

Troikaa 製药有限公司

最近的发展：

2023 年 5 月，Piramal Enterprises Ltd 与 plus Therapeutics 合作，以满足正在进行和计划中的临床试验的研究药物需求的成长。

2023 年 4 月，百特国际公司推出了 Zosyn Premix。适用于治疗敏感细菌引起的多种感染。

2021年12月，Hikma Pharmaceuticals PLC推出盐酸布比卡因注射液。盐酸布比卡因注射液适用于成人，用于手术、牙科和口腔手术、诊断和治疗程序以及产科手术中产生局部或区域麻醉或镇痛。

本报告回答的关键问题

  • 2022年全球吸入麻醉市场规模有多大
  • 2023-2028年全球吸入麻醉市场的预期成长率是多少
  • 推动全球吸入麻醉市场的关键因素是什么
  • COVID-19 对全球吸入麻醉市场有何影响
  • 基于产品的全球吸入麻醉市场的细分是什么
  • 基于应用的全球吸入麻醉市场的细分如何
  • 基于最终用户的全球吸入麻醉市场的细分是什么
  • 全球吸入麻醉市场的重点区域有哪些
  • 谁是全球吸入麻醉市场的主要参与者/公司

本报告回答的关键问题

  • 2022年全球吸入麻醉市场规模有多大？
  • 2023-2028年全球吸入麻醉市场的预期成长率是多少？
  • 推动全球吸入麻醉市场的关键因素是什么？
  • COVID-19 对全球吸入麻醉市场有何影响？
  • 基于该产品的全球吸入麻醉市场的细分情况如何？
  • 根据应用，全球吸入麻醉市场的细分如何？
  • 基于最终用户的全球吸入麻醉市场的细分情况如何？
  • 全球吸入麻醉市场的重点区域有哪些？
  • 全球吸入麻醉市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球吸入麻醉市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 地氟烷
    • 市场走向
    • 市场预测
  • 七氟醚
    • 市场走向
    • 市场预测
  • 异氟烷
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 就职
    • 市场走向
    • 市场预测
  • 维护
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbvie Inc.
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • Halocarbon Products Corporation
    • Hikma Pharmaceuticals PLC
    • Lunan Pharmaceutical Group Co. Ltd
    • Merck KGaA
    • Piramal Enterprises Ltd.
    • Troikaa Pharmaceuticals Ltd
Product Code: SR112023A3998

Abstract

The global inhalation anesthesia market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2028, exhibiting a growth rate (CAGR) of 2.9% during 2022-2028. The increasing prevalence of chronic medical disorders, collaborations between pharmaceutical companies, medical device manufacturers, and healthcare institutions, and the rising investments by governments and private healthcare providers in state-of-the-art equipment are some of the major factors propelling the market.

Inhalation anesthesia is a medical technique employed to induce a reversible state of unconsciousness and insensitivity to pain in patients undergoing various surgical procedures. This method involves administering anesthetic agents in the form of gases or vapors through a breathing mask or an endotracheal tube placed in the patient's airway. These anesthetic agents, such as nitrous oxide, sevoflurane, isoflurane, and desflurane, are carefully balanced to achieve the desired level of sedation and pain relief while maintaining vital bodily functions. The inhaled anesthetics travel through the patient's respiratory system, reaching the lungs and then entering the bloodstream, eventually affecting the brain and central nervous system.

The increasing prevalence of chronic medical disorders requiring surgical treatments is driving the global market. Moroever, as economies develop and individuals have better access to healthcare services, healthcare expenditure tends to increase. This includes investments in medical equipment and technologies, including anesthesia equipment. Governments and private healthcare providers are willing to invest in state-of-the-art equipment to improve patient care and safety. Moroever, regulations, and guidelines related to patient safety and anesthesia practices can impact the types of anesthesia agents and equipment used. Market growth is often aligned with compliance with these regulations, which can lead to the adoption of newer technologies and agents. Also, collaborations between pharmaceutical companies, medical device manufacturers, and healthcare institutions can lead to the development and promotion of new anesthesia technologies, impelling market expansion. Furthermore, the availability of skilled anesthesia professionals is crucial for administering inhalation anesthesia safely and effectively. Training programs and efforts to maintain a competent anesthesia workforce can impact the demand for these techniques.

Inhalation Anesthesia Market Trends/Drivers:

Continual Advancements in Anesthetic Agents and Delivery Systems

Pharmaceutical companies and medical device manufacturers are heavily investing in research and development to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus catalyzing the growth of the inhalation anesthesia market.

Rising Surgical Procedures and Patient Volume

Population growth, often accompanied by an aging demographic, directly correlates with a heightened demand for surgical procedures. The elderly population tends to require more medical interventions due to age-related ailments, such as cardiovascular diseases, joint replacements, and cancer treatments. Consequently, surgical specialties such as orthopedics, cardiology, oncology, and general surgery have seen a rise in demand. Inhalation anesthesia proves to be a preferred option for these procedures due to its rapid onset and controllable depth of sedation. It offers a balance between ensuring patient's unconsciousness and maintaining their physiological stability. Furthermore, the expansion of medical knowledge and technology has broadened the spectrum of feasible surgical interventions. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques have emerged, allowing for safer and quicker interventions.

Expansion of Ambulatory Surgical Centers

ASCs offer numerous advantages, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. Inhalation anesthesia aligns well with the requirements of ASCs due to its rapid onset and quick recovery profile. Patients undergoing procedures at ASCs often prefer inhalation anesthesia as it allows them to return to their daily activities more swiftly. Moreover, inhalation anesthesia's ability to minimize post-operative nausea and vomiting is particularly valuable in an outpatient setting. As the number of ASCs grows to accommodate the increasing demand for outpatient surgeries, the demand for inhalation anesthesia is expected to witness a significant rise. This trend also encourages manufacturers to develop more portable and user-friendly anesthesia delivery systems tailored to the unique needs of ASCs.

Inhalation Anesthesia Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global inhalation anesthesia market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Desflurane

Sevoflurane

Isoflurane

Others

Sevoflurane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes desflurane, sevoflurane, isoflurane, and others. According to the report, sevoflurane represented the largest segment.

Sevoflurane's popularity is largely due to its favorable pharmacokinetic profile. With its rapid induction and emergence characteristics, sevoflurane enables anesthesiologists to guide patients swiftly and smoothly into and out of anesthesia. This not only enhances operational efficiency in medical settings but also ensures that patients experience minimal delay in the start and conclusion of surgical procedures. Moreover, sevoflurane's low blood-gas solubility allows for rapid equilibration between the lungs and the bloodstream, translating into quicker adjustments in the depth of anesthesia and the potential for faster recoveries. Sevoflurane's reduced likelihood of causing organ toxicity or compromising vital functions offers a degree of reassurance to both medical professionals and patients. This safety aspect has been pivotal in cementing sevoflurane's role as a cornerstone of inhalation anesthesia practice, particularly in paediatric and geriatric populations where safety is of paramount concern.

Breakup by Application:

Induction

Maintenance

Maintenance dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes induction and maintenance. According to the report, maintenance represented the largest segment.

The prominence of the maintenance phase is attributed to its role in ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.

Hospitals offer a diverse range of medical services, encompassing routine surgeries, emergency interventions, and specialized procedures across various medical specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a substantial demand for anesthesia services, and inhalation anesthesia, with its ability to provide rapid induction and adjustable sedation levels, aligns seamlessly with the dynamic environment of hospital operating rooms. Additionally, hospitals provide a comprehensive infrastructure for anesthesia administration and patient care. They possess well-equipped operating suites, sophisticated monitoring systems, and experienced anesthesia teams capable of managing a wide spectrum of cases. This robust setup allows hospitals to efficiently manage the complexities associated with different surgeries, including those requiring inhalation anesthesia. Furthermore, the presence of specialized units within hospitals, such as pediatric and cardiac surgery departments, highlights the versatility of inhalation anesthesia across diverse patient populations and procedural requirements.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest inhalation anesthesia market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.

Competitive Landscape:

Pharmaceutical and medical device companies are heavily investing in research and development to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moroever, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anaesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbvie Inc.

Baxter International Inc.

Fresenius SE & Co. KGaA

Halocarbon Products Corporation

Hikma Pharmaceuticals PLC

Lunan Pharmaceutical Group Co. Ltd

Merck KGaA

Piramal Enterprises Ltd.

Troikaa Pharmaceuticals Ltd.

Recent Developments:

In May 2023, Piramal Enterprises Ltd collaborated with plus therapeutics to meet increase in investigational drug demand for ongoing and planned clinical trials.

In April 2023, Baxter International Inc. launched Zosyn Premix. It is indicated for the treatment of multiple infections caused by susceptible bacteria.

In December 2021, Hikma Pharmaceuticals PLC launched Bupivacaine HCl Injection. Bupivacaine HCl Injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.

Key Questions Answered in This Report

  • 1. What was the size of the global inhalation anesthesia market in 2022?
  • 2. What is the expected growth rate of the global inhalation anesthesia market during 2023-2028?
  • 3. What are the key factors driving the global inhalation anesthesia market?
  • 4. What has been the impact of COVID-19 on the global inhalation anesthesia market?
  • 5. What is the breakup of the global inhalation anesthesia market based on the product?
  • 6. What is the breakup of the global inhalation anesthesia market based on the application?
  • 7. What is the breakup of the global inhalation anesthesia market based on the end user?
  • 8. What are the key regions in the global inhalation anesthesia market?
  • 9. Who are the key players/companies in the global inhalation anesthesia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhalation Anesthesia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Desflurane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sevoflurane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Isoflurane
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Induction
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Maintenance
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbvie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Fresenius SE & Co. KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Halocarbon Products Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Hikma Pharmaceuticals PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Lunan Pharmaceutical Group Co. Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Merck KGaA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Piramal Enterprises Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Troikaa Pharmaceuticals Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
  • Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
  • Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
  • Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
  • Table 7: Global: Inhalation Anesthesia Market: Key Players